Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Net revenue	$ 950,294	$ 904,015
Cost of sales (exclusive of amortization shown separately below)	403,110	386,667
Amortization of acquired intangible assets	6,374	11,059
Total cost of sales	409,484	397,726
Gross profit	540,810	506,289
Operating Expenses
Selling, general, and administrative	193,933	176,719
Research and development	63,188	59,950
Amortization of acquired intangible assets	7,950	7,707
Total operating expenses	265,071	244,376
Income from operations	275,739	261,913
Other income (loss), net:
Interest (expense) income, net	(7,134)	(5,360)
Loss attributable to equity method investments (note 5)	(2,028)	(1,386)
Gain (loss) on equity investments (note 5)	(3,280)	5,612
Other, net	(1,504)	(1,991)
Total other income (loss), net	(13,946)	(3,125)
Income before income taxes	261,793	258,788
Income taxes	51,315	55,175
Net income	$ 210,478	$ 203,613
Basic earnings per share (dollars per share)	$ 1.44	$ 1.40
Diluted earnings per share (dollars per share)	1.43	1.39
Dividend declared per share (dollars per share)	$ 0.44	$ 0.42
Basic shares outstanding (000's) (in shares)	146,431	145,680
Diluted shares outstanding (000's) (in shares)	147,134	146,860
Total Sleep and Respiratory Care
Net revenue	$ 844,443	$ 806,499
Cost of sales (exclusive of amortization shown separately below)	363,844	349,681
Amortization of acquired intangible assets	1,228	900
Software as a Service
Net revenue	105,851	97,516
Cost of sales (exclusive of amortization shown separately below)	39,266	36,986
Amortization of acquired intangible assets	$ 5,146	$ 10,159